CLPTM1-Like (CLPTM1L) (AA 508-538), (C-Term) antibody

Details for Product No. ABIN951580
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms CRR9, C130052I12Rik, Crr9, RGD1307896, C130052I12RIK
AA 508-538, C-Term
(40), (22), (7), (2), (2), (2), (1), (1)
(64), (13), (13)
(7), (7), (7), (6), (6), (6), (1), (1), (1), (1), (1), (1), (1), (1)
Enzyme Immunoassay (EIA), Western Blotting (WB)
(55), (29), (12), (9), (2), (1)
Pubmed 5 references available
Quantity 0.4 mL
Shipping to United States (Change)
Availability Will be delivered in 6 to 8 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Catalog No. ABIN951580
357.50 $
Plus shipping costs $45.00

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen KLH conjugated synthetic peptide selected between amino acids 508-538 of human CLPTM1L
Isotype Ig
Specificity This antibody reacts to CLPTM1L.
Cross-Reactivity (Details) Species reactivity (tested):Human.
Purification Affinity chromatography on Protein A
Alternative Name CLPTM1-Like Protein
Background CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressedSynonyms: CLPTM1L, CRR9, CRR9p, Cisplatin resistance-related protein 9, Cleft lip and palate transmembrane protein 1-like protein
Molecular Weight 62229 Da
Gene ID 81037
NCBI Accession NP_110409
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS, 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Background publications Petersen, Amundadottir, Fuchs et al.: "A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33." in: Nature genetics, Vol. 42, Issue 3, pp. 224-8, 2010 (PubMed).

Wang, Broderick, Matakidou et al.: "Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers." in: Carcinogenesis, Vol. 31, Issue 2, pp. 234-8, 2010 (PubMed).

Landi, Chatterjee, Yu et al.: "A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma." in: American journal of human genetics, Vol. 85, Issue 5, pp. 679-91, 2009 (PubMed).

Broderick, Wang, Vijayakrishnan et al.: "Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study." in: Cancer research, Vol. 69, Issue 16, pp. 6633-41, 2009 (PubMed).

Chapuis, Hot, Hansmannel et al.: "Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease...." in: Molecular psychiatry, Vol. 14, Issue 11, pp. 1004-16, 2009 (PubMed).

Validation Images
Did you look for something else?
back to top